Michael R. Bishop, MD1, Michael Dickinson, MBBS2, Duncan Purtill3*, Pere Barba, MD, PhD4*, Armando Santoro5*, Nada Hamad6, Koji Kato, MD, PhD7, Anna Sureda8, Richard Greil, MD9, Catherine Thieblemont, MD, PhD10, Franck Morschhauser, MD, PhD11*, Martin Janz12*, Ian W. Flinn, MD, PhD13, Werner Rabitsch14*, Yok Lam Kwong15*, Marie José Kersten, MD, PhD16, Monique C. Minnema, MD17, Harald Holte, MD, PhD18, Esther Hian Li Chan19*, Joaquin Martinez-Lopez20*, Antonia MS Mueller, MD21, Richard T. Maziarz, MD22, Joseph P. McGuirk, DO23, Emmanuel Bachy, MD, PhD24*, Steven Le Gouill25, Martin Dreyling, MD PhD26, Hideo Harigae, MD, PhD27, David A. Bond, MD, BS28, Charalambos Andreadis, MD, MS29, Peter A. McSweeney, MD13, Mohamed A. Kharfan-Dabaja, MD, MBA30, Simon Newsome31*, Evgeny Degtyarev31*, Chris Del Corral, PharmD32*, Giovanna Andreola, MD31*, Aisha Masood, MD32, Stephen J Schuster, MD33, Ulrich Jaeger34, Peter Borchmann, MD35 and Jason R. Westin, MD36
1The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
2Peter MacCallum Cancer Centre and Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia
3Fiona Stanley Hospital, Murdoch, Western Australia, Australia
4Hospital Universitari Vall d’Hebron and Universitat Autonoma de Barcelona, Barcelona, Spain
5Department of Biomedical Sciences, Humanitas University and IRCCS Humanitas Research Hospital-Humanitas Cancer Center, Milan, Italy
6Department of Haematology, St Vincent's Hospital Sydney, Australia and St Vincent's Clinical School, Sydney, University of New South Wales, Sydney, NSW, Australia
7Hematology, Oncology, and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan
8Clinical Hematology Department, Institut Català d’Oncologia – Hospitalet de Llobregat, Barcelona, Spain
9Third Medical Department, Paracelsus Medical University; Salzburg Cancer Research Institute-CCCIT and Cancer Cluster Salzburg, Salzburg, Austria
10APHP, Hemato-Oncology, Hôpital Saint-Louis, Paris, France
11Centre Hospitalier Régional Universitaire de Lille, Lille, France
12Hematology, Oncology and Tumorimmunology, Charité, University Hospital Berlin, Campus Benjamin Franklin, Berlin, Germany
13Sarah Cannon Research Institute-Tennessee Oncology, Nashville, TN
14Internal Medicine I, BMT-Unit, Vienna General Hospital-Medical University of Vienna, Vienna, Austria
15Department of Medicine, Queen Mary Hospital, Hong Kong, China
16Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
17Universitair Medisch Centrum Utrecht, Dept Medical Oncology, Utrecht, Netherlands
18Department of Oncology, Oslo University Hospital, Oslo, Norway
19National University Cancer Institute, Signapore, Singapore
20Hospital 12 De Octubre, Complutense University, CNIO, Madrid, Spain
21Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland
22Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR
23Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Westwoon, KS
24Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France
25CRCINA, INSERM and Nantes Medical University, Nantes, France
26Medizinische Klinik 3, LMU Klinikum, Munich, Germany
27Tohoku University Hospital, Sendai, Japan
28The Ohio State University, Columbus, OH
29Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
30Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, FL
31Novartis Pharma AG, Basel, Switzerland
32Novartis Pharmaceuticals Corporation, East Hanover, NJ
33Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
34Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Vienna General Hospital – Medical University of Vienna, Vienna, Austria
35Clinic I for Internal Medicine, University Hospital Cologne, Cologne, Germany
36Department of Lymphoma & Myeloma, M.D. Anderson Cancer Center, Houston, TX